Lipid Nanoparticle-Based Inhibitors for SARS-CoV-2 Host Cell Infection
International Journal of Nanomedicine · 2024
DOI: 10.2147/ijn.s448005 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Vinith Yathindranath und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB, Canada. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, COVID-19, Liposomes, Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB, Canada.
- PrairieNeuro Research Centre, Health Science Centre, Winnipeg, MB, Canada.
- Children's Hospital Research Institute Manitoba, Health Science Centre, Winnipeg, MB, Canada.
ORCID-Profile: Vinith Yathindranath
Zitieren
APA
Yathindranath, V., Safa, N., Tomczyk, M. M., Dolinsky, V., & Miller, D. W. (2024). Lipid Nanoparticle-Based Inhibitors for SARS-CoV-2 Host Cell Infection. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s448005
Vancouver
Yathindranath V, Safa N, Tomczyk MM, Dolinsky V, Miller DW. Lipid Nanoparticle-Based Inhibitors for SARS-CoV-2 Host Cell Infection. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s448005
BibTeX
@article{Yathindranath2024,
author = {Yathindranath, Vinith and Safa, Nura and Tomczyk, Mateusz Marek and Dolinsky, Vernon and Miller, Donald W},
title = {Lipid Nanoparticle-Based Inhibitors for SARS-CoV-2 Host Cell Infection},
journal = {International Journal of Nanomedicine},
year = {2024},
doi = {10.2147/ijn.s448005}
}
EUVIMED